Skip to main content
. Author manuscript; available in PMC: 2018 Jul 5.
Published in final edited form as: Haemophilia. 2018 Feb 15;24(2):186–197. doi: 10.1111/hae.13424

TABLE 2. Per cent (%) of baseline anti-factor VIII IgG4 remaining after preanalytical heat treatment of plasma from haemophilia patients with given Nijmegen-Bethesda units (NBU), measured by fluorescence immunoassay in median fluorescence intensity (MFI) 78.

Baseline IgG4
(MFI)
% Remaining at 56°C
After
% Remaining at
58°C After
Specimens NBU 30′ 60′ 30′ 60′
Patient A 1.5   169 104  78  76 47
Patient B 1.6   1919 117 102  83 61
Patient C 19.3 12 596  91  92 100 75
Patient D 1.6 16 563  91  96  95 ND
Patient E 1.1   303 120 147  93 93
Patient F 1.1   1208 115 100  76 65
Patient G 0.5 17 194  80  93  72 39
Patient H 5.4 22 156  92  94  88 79
 Mean 101 100  85* 66*
 Range  80–120  78–147  72–93 39–93
*

Significantly different from original level in paired t test at P < .05; ND, no data.